Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.

Eloranta ML, Alm GV, Rönnblom L.

Arthritis Rheum. 2013 Apr;65(4):853-63. doi: 10.1002/art.37821. Review. No abstract available.

2.

B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.

Berggren O, Hagberg N, Weber G, Alm GV, Rönnblom L, Eloranta ML.

Arthritis Rheum. 2012 Oct;64(10):3409-19. doi: 10.1002/art.34599.

3.

IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.

Hagberg N, Berggren O, Leonard D, Weber G, Bryceson YT, Alm GV, Eloranta ML, Rönnblom L.

J Immunol. 2011 May 1;186(9):5085-94. doi: 10.4049/jimmunol.1003349. Epub 2011 Mar 23.

4.

The type I interferon system in the development of lupus.

Rönnblom L, Alm GV, Eloranta ML.

Semin Immunol. 2011 Apr;23(2):113-21. doi: 10.1016/j.smim.2011.01.009. Epub 2011 Feb 2. Review.

PMID:
21292501
5.

Type I interferon system activation and association with disease manifestations in systemic sclerosis.

Eloranta ML, Franck-Larsson K, Lövgren T, Kalamajski S, Rönnblom A, Rubin K, Alm GV, Rönnblom L.

Ann Rheum Dis. 2010 Jul;69(7):1396-402. doi: 10.1136/ard.2009.121400. Epub 2010 May 14.

PMID:
20472592
6.

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.

Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, Sturfelt G, Eloranta ML, Bengtsson AA.

Arthritis Rheum. 2009 Oct;60(10):3081-90. doi: 10.1002/art.24852.

7.

Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.

Eloranta ML, Lövgren T, Finke D, Mathsson L, Rönnelid J, Kastner B, Alm GV, Rönnblom L.

Arthritis Rheum. 2009 Aug;60(8):2418-27. doi: 10.1002/art.24686.

8.

Type I interferon and lupus.

Rönnblom L, Alm GV, Eloranta ML.

Curr Opin Rheumatol. 2009 Sep;21(5):471-7. doi: 10.1097/BOR.0b013e32832e089e. Review.

PMID:
19525849
9.

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.

Eloranta ML, Barbasso Helmers S, Ulfgren AK, Rönnblom L, Alm GV, Lundberg IE.

Arthritis Rheum. 2007 Sep;56(9):3112-24.

10.

Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.

Nordmark G, Alm GV, Rönnblom L.

Nat Clin Pract Rheumatol. 2006 May;2(5):262-9. Review.

PMID:
16932699
11.

Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

Lövgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Rönnblom L.

Arthritis Rheum. 2006 Jun;54(6):1917-27.

12.

The type I interferon system in systemic lupus erythematosus.

Rönnblom L, Eloranta ML, Alm GV.

Arthritis Rheum. 2006 Feb;54(2):408-20. Review. No abstract available.

13.

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

Båve U, Nordmark G, Lövgren T, Rönnelid J, Cajander S, Eloranta ML, Alm GV, Rönnblom L.

Arthritis Rheum. 2005 Apr;52(4):1185-95.

14.

Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.

Domeika K, Magnusson M, Eloranta ML, Fuxler L, Alm GV, Fossum C.

Vet Immunol Immunopathol. 2004 Sep;101(1-2):87-102.

PMID:
15261695
16.

Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity.

Rönnblom L, Eloranta ML, Alm GV.

Autoimmunity. 2003 Dec;36(8):463-72. Review.

PMID:
14984023
17.

The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.

Jönsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Rönnblom L, Alm GV, Sturfelt G.

Lupus. 2003;12(11):846-50.

PMID:
14667101
18.

Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.

Blomberg S, Eloranta ML, Magnusson M, Alm GV, Rönnblom L.

Arthritis Rheum. 2003 Sep;48(9):2524-32.

20.

Systemic lupus erythematosus and the type I interferon system.

Rönnblom L, Alm GV.

Arthritis Res Ther. 2003;5(2):68-75. Epub 2003 Jan 20.

21.

Characterisation of porcine monocyte-derived dendritic cells according to their cytokine profile.

Johansson E, Domeika K, Berg M, Alm GV, Fossum C.

Vet Immunol Immunopathol. 2003 Feb 10;91(3-4):183-97.

PMID:
12586481
22.

The natural interferon-alpha producing cells in systemic lupus erythematosus.

Rönnblom L, Alm GV.

Hum Immunol. 2002 Dec;63(12):1181-93. Review.

PMID:
12480262
23.
24.

Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide.

Magnusson M, Magnusson S, Vallin H, Rönnblom L, Alm GV.

Scand J Immunol. 2001 Dec;54(6):543-50.

25.

Veterinary immunology: opportunities and challenges.

Lunney JK, Fossum C, Alm GV, Steinbach F, Wattrang E.

Trends Immunol. 2002 Jan;23(1):4-6.

PMID:
11801442
26.

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus.

Rönnblom L, Alm GV.

J Exp Med. 2001 Dec 17;194(12):F59-63. Review. No abstract available.

27.
28.

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus.

Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Rönnblom L.

Lupus. 2001;10(7):484-90.

PMID:
11480846
29.

An etiopathogenic role for the type I IFN system in SLE.

Rönnblom L, Alm GV.

Trends Immunol. 2001 Aug;22(8):427-31. Review.

PMID:
11473831
30.

The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.

Båve U, Alm GV, Rönnblom L.

J Immunol. 2000 Sep 15;165(6):3519-26.

31.
35.

Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.

Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Rönnblom L.

J Autoimmun. 1998 Oct;11(5):465-70.

PMID:
9802930
36.

Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria.

Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV.

Scand J Immunol. 1997 Sep;46(3):235-41.

37.

Neutralising and binding anti-interferon-beta-I b (IFN-beta-I b) antibodies during IFN-beta-I b treatment of multiple sclerosis.

Kivisäkk P, Alm GV, Tian WZ, Matusevicius D, Fredrikson S, Link H.

Mult Scler. 1997 Jun;3(3):184-90.

PMID:
9310964
38.

The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry.

Svensson H, Johannisson A, Nikkilä T, Alm GV, Cederblad B.

Scand J Immunol. 1996 Aug;44(2):164-72.

PMID:
8711430
39.
40.
43.

Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.

Rönnblom LE, Janson ET, Perers A, Oberg KE, Alm GV.

Clin Exp Immunol. 1992 Sep;89(3):330-5.

44.

Interferon-alpha but not -beta genes require de novo protein synthesis for efficient expression in human monocytes.

Gobl AE, Cederblad B, Sandberg K, Alm GV.

Scand J Immunol. 1992 Feb;35(2):177-85.

PMID:
1310814
46.

A sensitive immunoassay for porcine interferon-alpha.

Diaz de Arce H, Artursson K, L'Haridon R, Perers A, La Bonnardiere C, Alm GV.

Vet Immunol Immunopathol. 1992 Jan 31;30(4):319-27.

PMID:
1372135
48.

Flow cytometric analysis of natural interferon-alpha producing cells.

Sandberg K, Eloranta ML, Johannisson A, Alm GV.

Scand J Immunol. 1991 Nov;34(5):565-76.

PMID:
1719613
50.

Phorbol ester-mediated inhibition of IFN-alpha/beta gene transcription in blood mononuclear leukocytes.

Sandberg K, Eloranta ML, Gobl AE, Alm GV.

J Immunol. 1991 Nov 1;147(9):3116-21.

PMID:
1655906

Supplemental Content

Support Center